FGF21 acting on the noradrenergic nervous system protects against influenza virus infection
Abstract
The hormone fibroblast growth factor 21 (FGF21) is induced in murine liver in response to both bacterial and viral infection. In this report, we show that FGF21 is induced by infection with influenza virus in both humans and mice. Mice lacking FGF21 had decreased food intake, body weight, and body temperature compared to wild-type mice following influenza virus inoculation, indicating reduced tolerance to the infection. Conversely, pharmacologic administration of FGF21 after viral infection protected mice against these pathologic changes. Pair feeding studies showed that neither the induction of FGF21 nor the hypothermia was secondary to decreased food intake. Notably, mice selectively lacking FGF21’s coreceptor protein, βKlotho, in noradrenergic neurons were also more susceptible to influenza virus infection, including hypothermia. We show that FGF21 acting on noradrenergic neurons, including those in the locus coeruleus region, stimulates energy expenditure and thermogenic gene expression in brown adipose tissue. Our findings reveal an FGF21-regulated neuronal pathway that protects mice against influenza infection and suggest the potential utility of using FGF21 pharmacologically to improve outcomes after influenza infection.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (10)
Wei Fan
State Key Laboratory of Silicon and Advanced Semiconductor Materials, School of Materials Science and Engineering
Yuan Zhang
Laurent Gautron
Center for Hypothalamic Research, Department of Internal Medicine, University of Texas Southwestern Medical Center
David G. Thomas
Heather W. Stout-Delgado
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine
Edward J. Schenck
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine
Tadiwanashe Gwatiringa
Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Texas Southwestern Medical Center
Kartik N. Rajagopalan
Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Texas Southwestern Medical Center
David J. Mangelsdorf
Department of Pharmacology, University of Texas Southwestern Medical Center
Steven A. Kliewer
Department of Pharmacology, University of Texas Southwestern Medical Center